References

No references inside the corpus for this window.

Cited by

• 2018The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act353 cited
• 1996Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil338 cited
• 1999Pharmacokinetics of Hoasca alkaloids in healthy humans318 cited
• 2016Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years306 cited
• 2017Potential Therapeutic Effects of Psilocybin299 cited
• 2017Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates273 cited
• 2022Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression248 cited
• 2019Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT247 cited
• 2019A systematic study of microdosing psychedelics235 cited
• 2004Hallucinogens and dissociative agents naturally growing in the United States219 cited
• 2016Clinical applications of hallucinogens: A review.201 cited
• 2023Extended difficulties following the use of psychedelic drugs: A mixed methods study201 cited
• 2018Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions